The 6 most recent market catalysts affecting $ADGM, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 23, 2026
Corporate Catalyst
Bearish
Impact 85
Adagio Medical shares are trading lower after the company announced a strategic alternatives review and a workforce reduction.
This headline indicates a company in distress, as a strategic alternatives review often implies that current operations are unsustainable or that the company is exploring a sale. T…
Sep 23, 2026
Corporate Catalyst
Neutral
Impact 95
Adagio Medical's Board Completes Strategic Review And Has Initiated A Formal Process To Explore Alternatives To Maximize Shareholder Value; May Include Acquisition, Merger, Business Combination, Or Other Transaction
Adagio Medical's announcement of exploring strategic alternatives, including a potential sale or merger, coupled with a workforce reduction, signals a critical juncture for the com…
Aug 4, 2026
Corporate Catalyst
Neutral
Impact 75
Adagio Medical Shares Resume Trade
The resumption of trading for a company's shares is a direct corporate catalyst, often following a significant announcement, regulatory review, or a period of extreme volatility. F…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 75
Adagio Medical Stock Is Trending Overnight: Here's Why ADGM Jumped 22% After Hours
Adagio Medical's stock surged over 20% after reporting the successful treatment of the first patient with its vCLAS Ultra ablation system for ventricular tachycardia. This is a sig…
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 75
Adagio Medical shares are trading higher after the company announced the treatment of the first patient with its next-generation vCLAS Ultra Ultra-Low Temperature Ablation system under Expanded Access authorization from the FDA.
This headline represents a significant positive catalyst for Adagio Medical. The successful treatment of the first patient with their next-generation vCLAS Ultra system, especially…
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 65
Adagio Medical Treats First Patient With Its vCLAS Ultra Ultra-Low Temperature Ablation System Under FDA's Expanded Access Authorization
Adagio Medical (ADGM) announced a significant clinical development: the first patient treatment with its vCLAS Ultra system under FDA Expanded Access. This event is a positive indi…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.